july, 2015

08julallday10allday13th Vaccines Research & Development: All Things Considered Conference


Event Details

Dear Colleague,

We are excited to announce GTCbio\’s 13th Vaccines Research & Development: All Things Considered Conference, which will take place July 8-10, 2015 in Boston, MA.

Newly emerging infections have opened up dialogue about the need for novel treatments and government response to these diseases. In the past year, the unprecedented Ebola outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges.

We invite you to join us as colleagues from industry and academia gather to discuss newly licensed vaccines, new vaccine technologies, and advances in hot topics such as RNA-based vaccines. In addition to scientific presentations and updates on research happening over the past year, colleagues will meet and connect in an accessible environment.

Sessions for the meeting include:

  1. Day 1 Plenary Session: Vaccines for the Developing World
    *includes special topic:
    Lessons Learned from the 2014 Ebola Outbreak
  2. Day 2 Plenary Session: Infectious Diseases: Where Are We and Where Are We Going?
  3. Adjuvants and Immune Stimulators
  4. New Delivery Systems
  5. Novel Approaches in RNA-Based Vaccines
  6. Immunotherapies
  7. Novel Vaccines and Technologies

Panel Discussions:

  • Challenges in Vaccines Development

We hope to see you there!

Best regards,

The 2015 Advisory Committee


july 8 (Wednesday) - 10 (Friday)


MassBio HQ

300 Technology Square, Cambridge, MA 02139